Skip to content

Degron Therapeutics vs PROTEINA

Degron Therapeutics logo

Degron Therapeutics

Aims to become a global leader in the discovery and development of molecular glue degraders

27 employees · est. 2021 · San Diego, United States

VS
PROTEINA logo

PROTEINA

Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements at the single-molecule level

32 employees · est. 2015 · Seoul, Korea South

PROTEINA is the older company (2021 vs 2015).

Side-by-Side Comparison

Degron Therapeutics PROTEINA
Founded
2021 2015 older
Headquarters
San Diego, United States Seoul, Korea South
Employees
27 32
Industry
Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Series A Series C
Total Funding
$82.00M $19.00B
Funding Rounds
6 2
Taxonomy
BiotechDrug DiscoveryMolecular Glue DegradersSmall Molecule InhibitorsTargeted Protein DegradationTherapeutics +9 Protein-protein InteractionPPI AnalysisSingle-molecule Co-immunoprecipitationQuantitative MeasurementsDrug Efficacy ModelingProtein Analysis +7
Website
degrontx.com proteina.co.kr
Degron Therapeutics logo

About Degron Therapeutics

Degron Therapeutics is a biotechnology startup founded in 2021 in the United States. The company's slogan "Aims to become a global leader in the discovery and development of molecular glue degraders" highlights its ambition in the industry. Degron Therapeutics is focused on pioneering a new class...

PROTEINA logo

About PROTEINA

PROTEINA is a biotechnology startup based in South Korea, founded in 2015. The company has revolutionized protein analysis with its first-in-class protein-protein interaction (PPI) analysis platform, utilizing proprietary 'single-molecule co-immunoprecipitation' technology for quantitative measureme...

Also comparing in this category

Comparing more than these two?

Get Degron Therapeutics, PROTEINA and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Degron Therapeutics compare?

A PDF of Degron Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Degron Therapeutics was founded in 2021, based in San Diego, United States, with 27 employees. Degron Therapeutics is a biotechnology startup founded in 2021 in the United States. The company's slogan "Aims to become a global leader in the discovery and development of molecular glue degraders". PROTEINA was founded in 2015, based in Seoul, Korea South, with 32 employees. PROTEINA is a biotechnology startup based in South Korea, founded in 2015. The company has revolutionized protein analysis with its first-in-class protein-protein interaction (PPI) analysis platform,.
Degron Therapeutics has raised $82.00M and PROTEINA $19.00B. Latest stage: Degron Therapeutics Series A, PROTEINA Series C.
Both work in Biotechnology and Health Care and list drug discovery and pharmaceutical research among their focus areas.

Compare Degron Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Degron Therapeutics on 12 Sep 2024, and PROTEINA on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout